Insider Transaction Report for Pardeep Nijhawan

Pardeep Nijhawan, Chief Executive Officer, Director, and 10% owner of Edesa Biotech, Inc., acquired 2,578 Common Shares on April 1, 2026. This acquisition, valued at $0.00, was part of a restricted share unit grant that vested in full upon grant, as per the Issuer's 2019 Equity Incentive Compensation Plan. Following this transaction, Mr. Nijhawan has a total of 631,391 shares. Of these, 402,702 shares are held by Pardeep Medicine Professional Corporation, 32,609 by The New Nijhawan Family Trust 2015, 32,013 by The Digestive Health Clinic Inc., and 53,104 by 1968160 Ontario Inc. Mr. Nijhawan disclaims beneficial ownership of the shares held by these entities, except to the extent of his pecuniary interest.